David Loomis Biography and Net Worth

CAO of Arvinas

David Loomis is the CAO of Arvinas. They are 52 years old.

What is David K. Loomis' net worth?: The estimated net worth of David K. Loomis is at least $410.64 thousand as of February 23rd, 2026. Loomis owns 29,692 shares of Arvinas stock worth more than $410,640 as of March 10th. This net worth approximation does not reflect any other assets that Loomis may own. Learn More about David K. Loomis' net worth.
How old is David K. Loomis?: Loomis is currently 50 years old. There are 8 older executives and no younger executives at Arvinas. The oldest executive at Arvinas is Dr. John A. Grosso Ph.D., Senior Vice President of R&D Technical Operations, who is 67 years old. Learn More on David K. Loomis' age.
How do I contact David K. Loomis?: The corporate mailing address for Loomis and other Arvinas executives is 5 SCIENCE PARK 395 WINCHESTER AVE, NEW HAVEN CT, 06511. Arvinas can also be reached via phone at (203) 535-1456 and via email at [email protected]. Learn More on David K. Loomis' contact information.
Has David K. Loomis been buying or selling shares of Arvinas?: During the last quarter, David K. Loomis has sold $25,553.52 of Arvinas stock. Most recently, David K. Loomis sold 1,108 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $12.16, for a transaction totalling $13,473.28. Following the completion of the sale, the chief accounting officer now directly owns 29,692 shares of the company's stock, valued at $361,054.72. Learn More on David K. Loomis' trading history.
Who are Arvinas' active insiders?: Arvinas' insider roster includes Noah Berkowitz (Chief Medical Officer), Sean Cassidy (CFO), John Houston (CEO), David Loomis (CAO), Bradley Margus (Director), Briggs Morrison (Director), Ronald Peck (Insider), Liam Ratcliffe (Director), Andrew Saik (Chief Financial Officer and Treasurer), Timothy Shannon (Director), Ian Taylor (Insider), and Randy Teel (CEO). Learn More on Arvinas' active insiders.
Are insiders buying or selling shares of Arvinas?: In the last year, Arvinas insiders bought shares 2 times. They purchased a total of 50,000 shares worth more than $495,100.00. In the last year, insiders at the sold shares 10 times. They sold a total of 72,017 shares worth more than $851,038.15. The most recent insider tranaction occured on March, 6th when Director Briggs Morrison bought 20,000 shares worth more than $268,000.00. Insiders at Arvinas own 4.7% of the company. Learn More about insider trades at Arvinas.
Information on this page was last updated on 3/6/2026.

David K. Loomis Insider Trading History at Arvinas

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2026	Sell	1,108	$12.16	$13,473.28	29,692
2/13/2026	Sell	1,016	$11.89	$12,080.24	30,800
11/7/2025	Sell	230	$9.89	$2,274.70	31,697
2/24/2025	Sell	1,214	$16.75	$20,334.50	18,863

David K. Loomis Buying and Selling Activity at Arvinas

Arvinas Company Overview

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. Arvinas, Inc. has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.

Today's Range

Now: $13.83

$13.75

$14.51

50 Day Range

MA: $12.69

$11.17

$13.83

2 Week Range

Now: $13.83

$5.90

$14.51

Volume

741,504 shs

Average Volume

846,313 shs

Market Capitalization

$884.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.87

David Loomis Biography and Net Worth

What is David K. Loomis' net worth?

How old is David K. Loomis?

How do I contact David K. Loomis?

Has David K. Loomis been buying or selling shares of Arvinas?

Who are Arvinas' active insiders?

Are insiders buying or selling shares of Arvinas?